Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rev. esp. enferm. dig ; 110(7): 446-450, jul. 2018. tab, graf
Artigo em Inglês | IBECS | ID: ibc-177709

RESUMO

Aims: To assess the expression of cathepsins in pancreatic samples obtained by endoscopic ultrasonography and fine needle aspiration (EUS-FNA) and to investigate their relationship with the staging of the pancreatic ductal adenocarcinoma (PDAC). Methods: We prospectively included patients with solid pancreatic masses, in which EUS-FNA were performed. Cathepsins B, L, S and H expression was determined in FNA samples. Results: Seventeen FNA were performed. All cytological material was from PDAC. Expression of cathepsins was predominantly low (B 65%, L 23%, S 76%, and H 41%). We found no correlation between the expression levels and the extension of the neoplasm. Conclusion: Expression of cathepsins in the cytological material of PDAC is diverse but still poor to be useful in the pre-operative diagnosis. There is no correlation between the expression levels of cathepsins and the extension of the PDAC


No disponible


Assuntos
Humanos , Neoplasias Pancreáticas/patologia , Aspiração por Agulha Fina Guiada por Ultrassom Endoscópico/métodos , Catepsinas/isolamento & purificação , Biomarcadores Tumorais/análise , Estudos Prospectivos , Carcinoma Ductal Pancreático/patologia , Reprodutibilidade dos Testes , Reprodutibilidade dos Testes
2.
Rev. esp. enferm. dig ; 108(12): 780-784, dic. 2016. tab, ilus
Artigo em Inglês | IBECS | ID: ibc-159625

RESUMO

Background and aims: To assess the expression levels of cathepsins in malignant and premalignant lesions. Methods: We retrospectively included patients who underwent pancreatic surgery on pancreatic solid or cystic masses. The expression of cathepsin H, L, B and S was determined in both types of samples. Lesions were divided into three categories: malignant (pancreatic adenocarcinoma and malignant mucinous neoplasms), premalignant (mucinous neoplasms) and benign (other lesions). Results: Thirty-one surgical resection samples were studied. The expression of cathepsins was significantly higher in malignant lesions than in premalignant and benign lesions (H 75%, 27%, 37% p = 0.05; L 92%, 36%, 37% p = 0.011; B 83%, 36%, 62% p = 0.069; S 92%, 36%, 25% p = 0.004, respectively). Conclusions: Cathepsins are overexpressed in histological samples of malignant lesions compared to premalignant and benign lesions. However, the expression of cathepsins is similar in both premalignant and benign lesions (AU)


No disponible


Assuntos
Humanos , Masculino , Feminino , Catepsinas/administração & dosagem , Catepsinas/análise , Neoplasias Pancreáticas/diagnóstico , Cistadenocarcinoma Mucinoso/complicações , Cistadenocarcinoma Mucinoso/diagnóstico , Estudos Retrospectivos , Imuno-Histoquímica/métodos , Imuno-Histoquímica , 28599
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA